WILSON SONS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.38 BRL | -1.50% |
|
-2.21% | -6.19% |
| May. 08 | Transcript : Wilson Sons S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company has a low valuation given the cash flows generated by its activity.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- One of the major weak points of the company is its financial situation.
- The company's enterprise value to sales, at 16.41 times its current sales, is high.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Marine Port Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -6.19% | 1.4B | - | ||
| +20.80% | 6.4B | - | B+ | |
| +9.59% | 1.99B | - | - | |
| -14.29% | 1.96B | C | ||
| +12.17% | 1.85B | - | C+ | |
| +29.76% | 1.15B | C+ | ||
| +18.58% | 1.02B | - | ||
| -.--% | 973M | - | - | |
| +35.67% | 707M | - | - | |
| +8.19% | 676M | - | B- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- PORT3 Stock
- Ratings Wilson Sons S.A.